Phase 1 Study of Recombinant Human Erythropoietin (rhEPO) in Parkinson's Disease (PD).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Recombinant erythropoietin (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
Most Recent Events
- 01 Oct 2019 Biomarkers information updated
- 17 Nov 2009 New trial record